SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter results for its fiscal 2010 on Thursday, May 6 following the close of trading on the New York Stock Exchange.
The company will host a webcast and conference call on May 6 at 2 p.m. Pacific time (5 p.m. Eastern time) to discuss the results for its third quarter, ended on March 31, 2010. To access the call and corresponding slide presentation, visit the Investor Relations page at www.carefusion.com or dial (800) 638-4817 within the U.S. or (617) 614-3943 from outside the U.S., and use the access code 62177129. A replay of the conference call will be available from 5 p.m. Pacific time (8 p.m. Eastern time) on May 6 through 8:59 p.m. Pacific time (11:59 p.m. Eastern time) on May 13 and can be accessed by dialing (888) 286-8010 in the U.S. or (617) 801-6888 Internationally and using the access code 97253184.
The conference call will also be webcast live on the Internet. Investors and other interested parties may access the live webcast through the Investor Relations section, under Calendar of Events, on CareFusion's website at www.carefusion.com.
Log on at least 15 minutes before the call begins to register and download or install any necessary audio software.
About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AirLife™, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for infection surveillance, V. Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.
|SOURCE CareFusion Corporation|
Copyright©2010 PR Newswire.
All rights reserved